References
- Lebwohl D, Canetta R. Clinical development of platinum complexes in cancer therapy: an historical perspective and an update. Eur J Cancer 1998;34:1522-34. https://doi.org/10.1016/S0959-8049(98)00224-X
- Arany I, Safirstein RL. Cisplatin nephrotoxicity. Semin Nephrol 2003;23:460-4. https://doi.org/10.1016/S0270-9295(03)00089-5
- Pabla N, Dong Z. Cisplatin nephrotoxicity: mechanisms and renoprotective strategies. Kidney Int 2008;73:994-1007. https://doi.org/10.1038/sj.ki.5002786
- Wang D, Lippard SJ. Cellular processing of platinum anticancer drugs. Nat Rev Drug Discov 2005;4:307-20. https://doi.org/10.1038/nrd1691
- Karasawa T, Steyger PS. An integrated view of cisplatin-induced nephrotoxicity and ototoxicity. Toxicol Lett 2015;237:219-27. https://doi.org/10.1016/j.toxlet.2015.06.012
- Ishida S, Lee J, Thiele DJ, Herskowitz I. Uptake of the anticancer drug cisplatin mediated by the copper transporter Ctr1 in yeast and mammals. Proc Natl Acad Sci USA 2002;99:14298-302. https://doi.org/10.1073/pnas.162491399
- Kuo YM, Gybina AA, Pyatskowit JW, Gitschier J, Prohaska JR. Copper transport protein (Ctr1) levels in mice are tissue specific and dependent on copper status. J Nutr 2006;136:21-6. https://doi.org/10.1093/jn/136.1.21
- Ludwig T, Riethmuller C, Gekle M, Schwerdt G, Oberleithner H. Nephrotoxicity of platinum complexes is related to basolateral organic cation transport. Kidney Int 2004;66:196-202. https://doi.org/10.1111/j.1523-1755.2004.00720.x
- Yonezawa A, Masuda S, Nishihara K, Yano I, Katsura T, Inui K. Association between tubular toxicity of cisplatin and expression of organic cation transporter rOCT2 (Slc22a2) in the rat. Biochem Pharmacol 2005;70:1823-31. https://doi.org/10.1016/j.bcp.2005.09.020
- TownsendDM,DengM, Zhang L, LapusMG, HaniganMH.Metabolismof cisplatin to a nephrotoxin in proximal tubule cells. J Am Soc Nephrol 2003;14:1-10. https://doi.org/10.1097/01.ASN.0000042803.28024.92
- Townsend DM, Marto JA, Deng M, Macdonald TJ, Hanigan MH. High pressure liquid chromatography and mass spectrometry characterization of the nephrotoxic biotransformation products of cisplatin. Drug Metab Dispos 2003;31:705-13. https://doi.org/10.1124/dmd.31.6.705
- Zhang L, Hanigan MH. Role of cysteine S-conjugate beta-lyase in the metabolism of cisplatin. J Pharmacol Exp Ther 2003;306:988-94. https://doi.org/10.1124/jpet.103.052225
- Taguchi T, Nazneen A, Abid MR, Razzaque MS. Cisplatin-associated nephrotoxicity and pathological events. Contrib Nephrol 2005;148:107-21.
- Chirino YI, Pedraza-Chaverri J. Role of oxidative and nitrosative stress in cisplatin-induced nephrotoxicity. Exp Toxicol Pathol 2009;61:223-42. https://doi.org/10.1016/j.etp.2008.09.003
- Choi KT. Botanical characteristics, pharmacological effects and medicinal components of Korean Panax ginseng C A Meyer. Acta Pharmacol Sin 2008;29:1109-18. https://doi.org/10.1111/j.1745-7254.2008.00869.x
- Ernst E. Panax ginseng: an overview of the clinical evidence. J Ginseng Res 2010;34:259-63. https://doi.org/10.5142/jgr.2010.34.4.259
- Kiefer D. Pantuso T. Panax ginseng. Am Fam Physician 2003;68:1539-42.
- Park HJ, Kim DH, Park SJ, Kim JM, Ryu JH. Ginseng in traditional herbal prescriptions. J Ginseng Res 2012;36:225-41. https://doi.org/10.5142/jgr.2012.36.3.225
- Baek SH, Bae ON, Park JH. Recent methodology in ginseng analysis. J Ginseng Res 2012;36:119-34. https://doi.org/10.5142/jgr.2012.36.2.119
- Helms S. Cancer prevention and therapeutics: Panax ginseng. Altern Med Rev 2004;9:259-74.
- Radad K, Gille G, Liu L, Rausch WD. Use of ginseng in medicine with emphasis on neurodegenerative disorders. J Pharmacol Sci 2006;100:175-86. https://doi.org/10.1254/jphs.CRJ05010X
- Cho IH. Effects of Panax ginseng in neurodegenerative diseases. J Ginseng Res 2012;36:342-53. https://doi.org/10.5142/jgr.2012.36.4.342
- Qi LW, Wang CZ, Yuan CS. American ginseng: potential structure-function relationship in cancer chemoprevention. Biochem Pharmacol 2010;80:947-54. https://doi.org/10.1016/j.bcp.2010.06.023
- Kwon SW, Han SB, Park IH, Kim JM, Park MK, Park JH. Liquid chromatographic determination of less polar ginsenosides in processed ginseng. J Chromatogr A 2001;921:335-9. https://doi.org/10.1016/S0021-9673(01)00869-X
- Park IH, Han SB, Kim JM, Piao L, Kwon SW, Kim NY, Kang TL, Park MK, Park JH. Four new acetylated ginsenosides from processed ginseng (sun ginseng). Arch Pharm Res 2002;25:837-41. https://doi.org/10.1007/BF02977001
- Park IH, Kim NY, Han SB, Kim JM, Kwon SW, Kim HJ, Park MK, Park JH. Three new dammarane glycosides from heat processed ginseng. Arch Pharm Res 2002;25:428-32. https://doi.org/10.1007/BF02976595
- Im W, Chung JY, Bhan J, Lim J, Lee ST, Chu K, Kim M. Sun ginseng protects endothelial progenitor cells from senescence associated apoptosis. J Ginseng Res 2012;36:78-85. https://doi.org/10.5142/jgr.2012.36.1.78
- Kim EJ, Oh HA, Choi HJ, Park JH, Kim DH, Kim NJ. Heat-processed ginseng saponin ameliorates the adenine-induced renal failure in rats. J Ginseng Res 2013;37:87-93. https://doi.org/10.5142/jgr.2013.37.87
- Lee CH, Kim JM, Kim DH, Park SJ, Liu X, Cai M, Hong JG, Park JH, Ryu JH. Effects of sun ginseng on memory enhancement and hippocampal neurogenesis. Phytother Res 2013;27:1293-9. https://doi.org/10.1002/ptr.4873
- Baek SH, Piao XL, Lee UJ, Kim HY, Park JH. Reduction of cisplatin-induced nephrotoxicity by ginsenosides isolated from processed ginseng in cultured renal tubular cells. Biol Pharm Bull 2006;29:2051-5. https://doi.org/10.1248/bpb.29.2051
- Kim YH, Kim YW, Oh YJ, Back NI, Chung SA, Chung HG, Jeong TS, Choi MS, Lee KT. Protective effect of the ethanol extract of the roots of Brassica rapa on cisplatin-induced nephrotoxicity in LLC-PK1 cells and rats. Biol Pharm Bull 2006;29:2436-41. https://doi.org/10.1248/bpb.29.2436
- Humanes B, Lazaro A, Camano S, Moreno-Gordaliza E, Lazaro JA, Blanco-Codesido M, Lara JM, Ortiz A, Gomez-Gomez MM, Martin-Vasallo P, et al. Cilastatin protects against cisplatin-induced nephrotoxicity without compromising its anticancer efficiency in rats. Kidney Int 2012;82:652-63. https://doi.org/10.1038/ki.2012.199
- Bellomo R, Kellum JA, Ronco C. Acute kidney injury. Lancet 2012;380:756-66. https://doi.org/10.1016/S0140-6736(11)61454-2
- Zsengeller ZK, Ellezian L, Brown D, Horvath B, Mukhopadhyay P, Kalyanaraman B, Parikh SM, Karumanchi SA, Stillman IE, Pacher P. Cisplatin nephrotoxicity involves mitochondrial injury with impaired tubular mitochondrial enzyme activity. J Histochem Cytochem 2012;60:521-9. https://doi.org/10.1369/0022155412446227
- Sanchez-Gonzalez PD, Lopez-Hernandez FJ, Perez-Barriocanal F, Morales AI, Lopez-Novoa JM. Quercetin reduces cisplatin nephrotoxicity in rats without compromising its anti-tumour activity. Nephrol Dial Transplant 2011;26:3484-95. https://doi.org/10.1093/ndt/gfr195
- Lopez MV, Cuadrado MP, Ruiz-Poveda OM, Del Fresno AM, Accame ME. Neuroprotective effect of individual ginsenosides on astrocytes primary culture. Biochim Biophys Acta 2007;1770:1308-16. https://doi.org/10.1016/j.bbagen.2007.06.008
- Shen L, Han JZ, Li C, Yue SJ, Liu Y, Qin XQ, Liu HJ, Luo ZQ. Protective effect of ginsenoside Rg1 on glutamate-induced lung injury. Acta Pharmacol Sin 2007;28:392-7. https://doi.org/10.1111/j.1745-7254.2007.00511.x
- Zhang MH, Fan JM, Xie XS, Deng YY, Chen YP, Zhen R, Li J, Cheng Y, Wen J. Ginsenoside-Rg1 protects podocytes from complement mediated injury. J Ethnopharmacol 2011;137:99-107. https://doi.org/10.1016/j.jep.2011.04.045
- Zhou XM, Cao YL, Dou DQ. Protective effect of ginsenoside-Re against cerebral ischemia/reperfusion damage in rats. Biol Pharm Bull 2006;29:2502-5. https://doi.org/10.1248/bpb.29.2502
- Park JY, Choi P, Kim T, Ko H, Kim HK, Kang KS, Ham J. Protective effects of processed ginseng and its active ginsenosides on cisplatin-induced nephrotoxicity: in vitro and in vivo studies. J Agric Food Chem 2015;63:5964-9. https://doi.org/10.1021/acs.jafc.5b00782
Cited by
- Anti-anemia effects of ginsenoside Rk3 and ginsenoside Rh4 on mice with ribavirin-induced anemia vol.9, pp.4, 2018, https://doi.org/10.1039/c8fo00368h
- Total Synthesis and Biological Evaluation of Sericetin for Protection against Cisplatin-Induced Acute Kidney Injury vol.81, pp.12, 2017, https://doi.org/10.1021/acs.jnatprod.8b00434
- Protective Role of Natural Products in Cisplatin-Induced Nephrotoxicity vol.19, pp.14, 2019, https://doi.org/10.2174/1389557519666190320124438
- Ginsenoside Rk3 ameliorates high-fat-diet/streptozocin induced type 2 diabetes mellitus in mice via the AMPK/Akt signaling pathway vol.10, pp.5, 2019, https://doi.org/10.1039/c9fo00095j
- Possible protective effect of platelet‐rich plasma on a model of cisplatin‐induced nephrotoxicity in rats: A light and transmission electron microscopic study vol.234, pp.7, 2017, https://doi.org/10.1002/jcp.27706
- Catalpol-Induced AMPK Activation Alleviates Cisplatin-Induced Nephrotoxicity through the Mitochondrial-Dependent Pathway without Compromising Its Anticancer Properties vol.2021, pp.None, 2017, https://doi.org/10.1155/2021/7467156
- Endoplasmic Reticulum Stress-Activated PERK-eIF2α-ATF4 Signaling Pathway is Involved in the Ameliorative Effects of Ginseng Polysaccharides against Cisplatin-Induced Nephrotoxicity in Mice vol.6, pp.13, 2017, https://doi.org/10.1021/acsomega.0c06339